On Tuesday, June 14, Endpoints News EIC John Carroll sat down with a group of biotech execs to discuss the bear market for industry stocks and how they were dealing with it. Here’s the conversation, […]
This week’s Lab Notes has items on a Chester County company’s ongoing pursuit of approval for its lead drug candidate, a Bucks County company exploring its options after generating positive study results for an experimental […]
Company provides anticipated impact to second quarter 2022 financial results due to recently completed business development transactions TARRYTOWN, N.Y., July 1, 2022 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it has completed […]
Focus is now on NRX-101 for Bipolar Depression with Suicidality RADNOR, Pa., July 1, 2022 /PRNewswire/ — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), (“NRx Pharmaceuticals”), a clinical-stage biopharmaceutical company, today announced that the US Food and […]
The promise of new drug therapies still exists in Buffalo, but the challenges are severe. Click here to view original post
Paul Moore → Zymeworks used a poison pill maneuver a couple weeks ago as the counterpunch to a $773 million takeover bid by All Blue Falcons, and new CEO Kenneth Galbraith isn’t done piecing the […]
SAN DIEGO — From San Diego to New Jersey, biotechs developing new forms of birth control say they’re doubling down on those efforts after Roe v. Wade was overturned — even as the Supreme Court’s […]
Reed has been president and CEO of the health system since 2012. Click here to view original post
It’s not just about state-of-the-art technology and top-notch research. Click here to view original post
How the personal and the clinical combine for Allegheny Health Network’s treatment of cancer. Click here to view original post
Copyright © 2022 Biotech Networks, LLC
